Search Results

You are looking at 1 - 10 of 180 items for :

  • "lymph node dissection" x
Clear All
Full access

George Plitas and Charlotte E. Ariyan

melanoma has been guided by many multicenter randomized trials that have shaped management decisions. Treatment has evolved from elective lymph node dissections to newer strategies identifying the most at-risk patients through sentinel lymph node (SLN

Full access

Elizabeth G. Grubbs and Douglas B. Evans

extensive lymph node dissection: metastatic lymph nodes in papillary carcinoma of the thyroid] . Nippon Geka Gakkai Zasshi 1986 ; 87 : 883 – 888 [in Japanese] . 5. Tisell LE Nilsson B Molne J . Improved survival of patients with papillary

Full access

Nawin Kuntaraksa

Objective: The primary objective was to evaluate seroma formation in a comparison between the lymphatic ligation technique and conventional axillary lymph node dissection. The secondary objective was to evaluate the factors affecting seroma

Full access

James Sun, Brittany J. Mathias, Christine Laronga, Weihong Sun, Jun-Min Zhou, William J. Fulp, John V. Kiluk and M. Catherine Lee

Background Surgical management of invasive breast cancer has moved toward less-invasive measures, including axillary management. Axillary lymph node dissection is associated with significant morbidity and complications (wound infections, seromas

Full access

Anthony J. Olszanski

biopsy. After a diagnosis of stage III disease based on SLN biopsy, the previous version of the NCCN Guidelines stated that these patients should undergo complete lymph node dissection (CLND). “’The questions we had to ask were, ‘Is that something we

Full access

Jaffer A. Ajani, David J. Bentrem, Stephen Besh, Thomas A. D’Amico, Prajnan Das, Crystal Denlinger, Marwan G. Fakih, Charles S. Fuchs, Hans Gerdes, Robert E. Glasgow, James A. Hayman, Wayne L. Hofstetter, David H. Ilson, Rajesh N. Keswani, Lawrence R. Kleinberg, W. Michael Korn, A. Craig Lockhart, Kenneth Meredith, Mary F. Mulcahy, Mark B. Orringer, James A. Posey, Aaron R. Sasson, Walter J. Scott, Vivian E. Strong, Thomas K. Varghese Jr, Graham Warren, Mary Kay Washington, Christopher Willett, Cameron D. Wright, Nicole R. McMillian and Hema Sundar

second most common cause of cancer-related death worldwide. In 2013, an estimated 21,600 new cases will be diagnosed and 10,990 people will die of the disease in United States. 1 Surgery with lymph node dissection is the primary treatment for patients

Full access

William C. Huang and Bernard H. Bochner

Gschwend JE Herr HW . Pelvic lymph node dissection can be curative in patients with node positive bladder cancer . J Urol 1999 ; 161 : 449 – 454 . 7. Leissner J Ghoneim MA Abol-Enein H . Extended radical lymphadenectomy in patients with

Full access

Scott M. Gilbert and Brent K. Hollenbeck

retroperitoneal lymph node dissection in the management of testicular cancer . Urol Oncol 2004 ; 22 : 225 – 233 . 10 Fisher B Anderson S Bryant J . Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy

Full access

Jason P. Wilson, David Mattson and Stephen B. Edge

trial, combined with the results of the NSABP B-06 trials, changed the standard therapy from radical mastectomy to breast-conserving therapy, with axillary lymph node dissection (AND) performed for staging and local control. 2 In 1994, sentinel lymph

Full access

Victor T.G. Lin, Lisle M. Nabell, Sharon A. Spencer, William R. Carroll, Shuko Harada and Eddy S. Yang

below it. Dose reductions, holds, and discontinuations, and palliative radiotherapies are not shown for the sake of simplicity. Abbreviations: LND, lymph node dissection; RT, radiation therapy. for phase I clinical trials and limited